1xbet 로그인., Ltd.

Enables Test Sample Collection from Front of Nasal Cavity, in Conjunction withQuick Navi^™-Flu2 1xbet 로그인 Quick Navi^™-COVID19 Ag Diagnostic Kits

1xbet 로그인., Ltd. (Otsuka) and Denka Company, Limited announce that on October 30, a change in manufacturing and marketing approval for the influenza virus antigen rapid diagnostic kit Quick Navi^™-Flu2 was granted in Japan by the Ministry of Health, Labour 1xbet 로그인 Welfare.

With the change in approval, a single test swab can be used to collect a test sample from the front of the patient's nasal cavity 1xbet 로그인 that sample can then be used for simultaneous testing in conjunction with the influenza virus antigen rapid diagnostic kit Quick Navi^™-Flu2 1xbet 로그인 the COVID-19 antigen rapid diagnostic kit Quick Navi^™-COVID19 Ag. The Japanese Association for Infectious Diseases recommends that patients be tested simultaneously for influenza 1xbet 로그인 COVID-19.

The Quick Navi^™- Flu2 1xbet 로그인 the Quick Navi^™-COVID-19 Ag tests enable patients themselves to collect a sample from the front of their nasal cavity, when done under the supervision of medical staff. Alternatively, medical staff themselves can use the existing method of using a nasopharyngeal swab to collect a test sample from the back of the naval cavity.

Use of a single sample to test for two different viruses aids the physician in rapid 1xbet 로그인 accurate diagnosis. The potential reemergence of simultaneous COVID-19 1xbet 로그인 influenza epidemics during the autumn 1xbet 로그인 winter months ahead illustrates the heightened importance of early diagnosis 1xbet 로그인 treatment.

1xbet 로그인 regards countermeasures against infectious diseases as a social responsibility, and together with Denka, aims to advance clinical testing and prompt and appropriate medical care through the provision of this product to domestic medical institutions.